Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
Clinical trial NCT04588545 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04588545
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2027-04-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.